期刊文献+

应用液体蛋白芯片飞行时间质谱技术研究原发性肝癌门静脉癌栓形成相关标志物 被引量:1

Serum protein biomarkers for portal vein tumor thrombus in hepatocellular carcinorma detected by ClinProt system
下载PDF
导出
摘要 目的应用液体蛋白质芯片飞行时间质谱技术研究肝癌门静脉癌栓(portal vein tumor thrombus,PVTT)形成相关标志物,并建立预测模型。方法采取非PVTT和PVTT原发性肝癌(hepatocellularcarcinoma,HCC)患者血清各20例,采用磁珠分离系统纯化、基质辅助激光解析电离飞行时间质谱(matrix-assisted laser desorption/ionization ti me of flight mass spectrometry,MALDI-TOF-MS)分析及ClinProTools生物信息学方法研究其血清蛋白表达谱,通过神经网络算法(statistical neural networks,SNN)建立图谱诊断模型并进行验证。结果经数据对比分析找到39个差异有统计学意义的质荷比(m/z)峰(P<0.05),从中筛选出最具划分能力的8个质荷比峰(m/z=4 420.43、4 055.19、2 988.80、4 091.46、4 072.24、6 935.04、4 109.53和5 321.17),并以此建立HCC的PVTT诊断模型,模型识别率达到97.5%,而预测率达到92.73%。非PVTT组和PVTT组的准确性分别为100%和95%。结论筛选得到的蛋白可能成为原发性肝癌PVTT的相关标志物,诊断模型可能对预测PVTT的形成具有重要临床意义。 Objective To screen potential protein biomarkers associated with the formation of portal vein tumor thrombus(PVTT) in hepatocellular carcinoma(HCC) patients,and to build a predictive model. Methods The serum samples from 40 HCC patients(20 with PVTT and 20 free of PVTT) were enriched by the magnetic bead and analyze by matrix-assisted laser desorption/ionization time of flight mass spectrometry(MALDI-TOF-MS) and ClinProTools,respectively.Diagnostic model was established and identified by statistical neural networks(SNN). Results Thirty-nine peaks with significant statistical differences in mass charge ratio(m/z) were found(P0.05).Eight protein peaks(m/z=4 420.43,4 055.19,2 988.80,4 091.46,4 072.24,6 935.04,4 109.53 and 5 321.17) among them were selected to establish the predictive model of PVTT.Specificity and accuracy of this model was 97.5% and 92.73%,repectively.Predictive values in patients with and without PVTT were 100% and 95%. Conclusions These 8 protein peaks may be potential biomarkers of PVTT in HCC patients,and the predictive model may have great clinical significance in predicting the formation of PVTT.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2010年第4期459-463,共5页 Fudan University Journal of Medical Sciences
关键词 原发性肝癌 门静脉癌栓 液体蛋白芯片飞行时间质谱 蛋白质组 hepatocellular carcinorma portal vein tumor thrombus ClinProt system proteome
  • 相关文献

参考文献6

二级参考文献110

  • 1ALAOUI-JAMALI Moulay A..Review:Proteomic technology for biomarker profiling in cancer: an update[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2006,7(6):411-420. 被引量:9
  • 2张青云.肿瘤标志物临床检测技术现状及发展趋势[J].中华检验医学杂志,2006,29(7):585-589. 被引量:29
  • 3俸家富,涂植光.蛋白质组学在肿瘤研究中的应用[J].实用癌症杂志,2006,21(4):433-436. 被引量:5
  • 4Fearnley JM, Lees AJ. Ageing and Parkinson' s disease: substantia nigra regional selectivity. Brain, 1991, 114: 2283- 2301.
  • 5Riederer P, Wuketich S. Time course of nigrostriatal degeneration in Parkinson' s disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm, 1976, 38: 277- 301.
  • 6Dotzlaw H, Schulz M, Eggert M, et al. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta, 2004, 1696: 121-129.
  • 7Kang X, Xu Y, Wu X, et al. Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clin Chem, 2005, 51 : 56-64.
  • 8Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson' s Disease Reting Scale: Motor Examination section. Mov Disord, 1998, 13: 633-636.
  • 9de Rijk MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson ' s disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson' s disease. J Neurol Neurosurg Psychiatry, 1997, 62: 10-15.
  • 10Abe T, Isobe C, Murata T, et al. Aheration of 8- hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parksinson ' s disease. Neurosci Lett, 2003, 336 : 105-108.

共引文献114

同被引文献12

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部